"Urologists today are armed with 2 guideline-supported modalities to reduce the burden of unnecessary biopsies while maintaining timely detection of clinically significant cancers," write the authors.
Cameron J. Britton, MD
Advertisement
Articles by Cameron J. Britton, MD
Cameron J. Britton, MD, highlights key findings from a study of the MyProstateScore 2.0 in predicting upgrading to GG≥3 prostate cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Clinical Application of MMAI Score in Patients with Prostate Cancer
2
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
3
Setting the Stage: ADT in Intermediate-Risk Prostate Cancer
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5